Peter M. O’Neill

Cellectis, New York, NY, United States

Articles by Peter M. O’Neill

A Digital Twin on CAR-T Cytokine Release Syndrome (CRS) Patients with Standard of Care Measured by CRS Distribution by Grade

ByGen Li, PhD, MBA,Jonathan Peachey,Paul Chew, MD,Peter M. O’Neill

May 26th 2023

Using existing clinical trial data to proactively model patient safety and efficacy outcomes could aid in accelerating development for areas in need of new therapies.

Peter M. O’Neill

Articles by Peter M. O’Neill

A Digital Twin on CAR-T Cytokine Release Syndrome (CRS) Patients with Standard of Care Measured by CRS Distribution by Grade

Latest Updated Articles

Trending on Applied Clinical Trials Online

FDA Pauses Real-Time Release of Drug Rejection Letters While Working to Formalize Policy

ACT Brief: Simplifying Trials Through Selective Safety Data, AI-Driven Site Partnerships, and Biopharma Strategic Pivots

ACT Brief: Single Pivotal Trial Stakes, Configurable FSP Strategy, and G-CSF Biosimilar Portfolio Expansion

ACT Brief: Multimodal AI Systems Architecture, Trust-Based Trial Recruitment, and Big Pharma AI Transformation

AI-Enabled Sites and the Future of Trial Planning: Q&A with Liz Beatty, Inato